| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 150, 257-266, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
W Rudin, HP Eugster, G Bordmann, J Bonato, M Muller, M Yamage and B Ryffel
Swiss Tropical Institute, Basel, Switzerland.
Tumor necrosis factor (TNF) induced by Plasmodium berghei ANKA (PbA) infection was suggested to play an important role in the development of cerebral malaria (CM). We asked whether TNF-alpha/beta double-deficient mice, which have a complete disruption of the TNF-signaling pathways, are protected from CM and what might be the possible mechanisms of protection. PbA infection induces fatal CM in wild-type mice, which die within 5 to 8 days with severe neurological signs. In contrast, TNF- alpha/beta-deficient mice are completely resistant to PbA-induced CM. As PbA-induced up-regulation of endothelial intercellular adhesion molecule (ICAM)-1 expression as well as the systemic release of nitric oxide is found only in wild-type mice, TNF is apparently central for the recruitment of mononuclear cells and microvascular damage. Mononuclear cell adhesion to the endothelium, vascular leak and, perivascular hemorrhage are found only in the brain of wild-type mice. By contrast, the development of parasitemia and anemia is independent of TNF. Resistance to CM in TNF-alpha/beta-deficient mice is associated with reduced interferon-gamma and interleukin-12 expression in the brain, in the absence of increased T helper type 2 cytokines. In conclusion, TNF apparently is required for PbA-induced endothelial ICAM- 1 up-regulation and subsequent microvascular pathology resulting in fatal CM. In the absence of TNF, ICAM-1 and nitric oxide up-regulation are reduced, and PbA infection fails to cause fatal CM.
This article has been cited by other articles:
![]() |
A. M. Vigario, E. Belnoue, A. C. Gruner, M. Mauduit, M. Kayibanda, J.-C. Deschemin, M. Marussig, G. Snounou, D. Mazier, I. Gresser, et al. Recombinant Human IFN-{alpha} Inhibits Cerebral Malaria and Reduces Parasite Burden in Mice J. Immunol., May 15, 2007; 178(10): 6416 - 6425. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Togbe, L. Schofield, G. E. Grau, B. Schnyder, V. Boissay, S. Charron, S. Rose, B. Beutler, V. F.J. Quesniaux, and B. Ryffel Murine Cerebral Malaria Development Is Independent of Toll-Like Receptor Signaling Am. J. Pathol., May 1, 2007; 170(5): 1640 - 1648. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. WASSMER, V. COMBES, and G. E. GRAU Pathophysiology of Cerebral Malaria: Role of Host Cells in the Modulation of Cytoadhesion Ann. N.Y. Acad. Sci., May 1, 2003; 992(1): 30 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Akassoglou, E. Douni, J. Bauer, H. Lassmann, G. Kollias, and L. Probert Exclusive tumor necrosis factor (TNF) signaling by the p75TNF receptor triggers inflammatory ischemia in the CNS of transgenic mice PNAS, January 21, 2003; 100(2): 709 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Engwerda, T. L. Mynott, S. Sawhney, J. B. De Souza, Q. D. Bickle, and P. M. Kaye Locally Up-regulated Lymphotoxin {alpha}, Not Systemic Tumor Necrosis Factor {alpha}, Is the Principle Mediator of Murine Cerebral Malaria J. Exp. Med., May 20, 2002; 195(10): 1371 - 1377. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nagayasu, K. Nagakura, M. Akaki, G. Tamiya, S. Makino, Y. Nakano, M. Kimura, and M. Aikawa Association of a Determinant on Mouse Chromosome 18 with Experimental Severe Plasmodium berghei Malaria Infect. Immun., February 1, 2002; 70(2): 512 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Pedras-Vasconcelos, L. R. Brunet, and E. J. Pearce Profound effect of the absence of IL-4 on T cell responses during infection with Schistosoma mansoni J. Leukoc. Biol., November 1, 2001; 70(5): 737 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lou, R. Lucas, and G. E. Grau Pathogenesis of Cerebral Malaria: Recent Experimental Data and Possible Applications for Humans Clin. Microbiol. Rev., October 1, 2001; 14(4): 810 - 820. [Abstract] [Full Text] |
||||
![]() |
P. F. Piguet, C. Da Kan, C. Vesin, A. Rochat, Y. Donati, and C. Barazzone Role of CD40-CD40L in Mouse Severe Malaria Am. J. Pathol., August 1, 2001; 159(2): 733 - 742. [Abstract] [Full Text] |
||||
![]() |
P. F. Piguet, C. Da Laperrousaz, C. Vesin, F. Tacchini-Cottier, G. Senaldi, and G. E. Grau Delayed Mortality and Attenuated Thrombocytopenia Associated with Severe Malaria in Urokinase- and Urokinase Receptor-Deficient Mice Infect. Immun., July 1, 2000; 68(7): 3822 - 3829. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Deckert-Schluter, H. Bluethmann, N. Kaefer, A. Rang, and D. Schluter Interferon-{gamma} Receptor-Mediated but Not Tumor Necrosis Factor Receptor Type 1- or Type 2-Mediated Signaling Is Crucial for the Activation of Cerebral Blood Vessel Endothelial Cells and Microglia in Murine Toxoplasma Encephalitis Am. J. Pathol., May 1, 1999; 154(5): 1549 - 1561. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Jennings, A. A. Lal, and R. L. Hunter Evidence for Multiple Pathologic and Protective Mechanisms of Murine Cerebral Malaria Infect. Immun., December 1, 1998; 66(12): 5972 - 5979. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Amani, M. I. Boubou, S. Pied, M. Marussig, D. Walliker, D. Mazier, and L. Renia Cloned Lines of Plasmodium berghei ANKA Differ in Their Abilities To Induce Experimental Cerebral Malaria Infect. Immun., September 1, 1998; 66(9): 4093 - 4099. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Stalder, M. J. Carson, A. Pagenstecher, V. C. Asensio, C. Kincaid, M. Benedict, H. C. Powell, E. Masliah, and I. L. Campbell Late-Onset Chronic Inflammatory Encephalopathy in Immune-Competent and Severe Combined Immune-Deficient (SCID) Mice with Astrocyte-Targeted Expression of Tumor Necrosis Factor Am. J. Pathol., September 1, 1998; 153(3): 767 - 783. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoshimoto, Y. Takahama, C.-R. Wang, T. Yoneto, S. Waki, and H. Nariuchi A Pathogenic Role of IL-12 in Blood-Stage Murine Malaria Lethal Strain Plasmodium berghei NK65 Infection J. Immunol., June 1, 1998; 160(11): 5500 - 5505. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |